Cbd Global Sciences Inc (CBDN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 93 | 1 | 22 |
| Receivables | 24 | 3 | 358 |
| Inventories | 189 | 0 | 3,374 |
| TOTAL | $320 | $308 | $3,772 |
| Non-Current Assets | |||
| PPE Net | 1,375 | 80 | 2,198 |
| Intangibles | 332 | N/A | N/A |
| Other Non-Current Assets | 64 | 84 | 178 |
| TOTAL | $1,772 | $164 | $2,376 |
| Total Assets | $2,092 | $472 | $6,148 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 561 | 394 | 3,946 |
| Accounts payable and accrued liabilities | 327 | 1,059 | 817 |
| Accrued Expenses | 747 | 819 | 768 |
| Other current liabilities | 274 | 373 | 0 |
| TOTAL | $2,056 | $3,548 | $5,775 |
| Non-Current Liabilities | |||
| Long Term Debt | 1,338 | 3,916 | 490 |
| Deferred Revenues | 2 | 25 | 25 |
| Other Non-Current Liabilities | 10 | 1,212 | 401 |
| TOTAL | $1,732 | $5,200 | $1,532 |
| Total Liabilities | $3,787 | $8,748 | $7,307 |
| Shareholders' Equity | |||
| Common Shares | 8,901 | 6,561 | 5,129 |
| Retained earnings | -26,420 | -21,168 | -12,240 |
| Other shareholders' equity | 6,058 | 4,253 | 3,874 |
| TOTAL | $-1,696 | $-8,275 | $-1,158 |
| Total Liabilities And Equity | $2,092 | $472 | $6,148 |